The maximum solubility of TFMB-R-2HG (867 mM in DMSO) prevents its application at the high millimolar concentrations that are physiologically relevant for IDH-mutant gliomas (up to 30 mM) (5, 22). This evidence concerns the gene IDH1 and central nervous system cancer.